INTRODUCTION 1 2
Hepatitis C virus (HCV) infection is one of the leading causes of chronic 3 hepatitis. HCV infection is associated with cirrhosis, steatosis and hepatocellular 4 carcinoma (33). The HCV RNA genome of ~9.6 kb is translated via an internal 5 ribosome entry site (IRES) element on the rough endoplasmic reticulum (ER) as a 6 polyprotein precursor of about 3010 amino acids that is co-and post-translationally 7 processed by cellular and viral proteases into mature structural and nonstructural (NS) 8 proteins (33). HCV replicates within ribonucleoprotein complexes (RNP) associated 9 with modified ER membranous structures (15). Recent work implicated lipid droplets 10 that emanate from the ER as sites of RNA replication (28, 44) . Almost all of the HCV 11 NS proteins along with a variety of cellular factors are associated with the RNP 12 complexes engaged in viral RNA replication (37). It is likely that these NS proteins not 13 only participate in replication process but also are involved in the various steps of virion 14 morphogenesis and assembly. Membrane-associated RNP complexes are generally 15 composed of viral proteins, replicating RNA and host proteins and altered cellular 16 membranes (1). In this respect, a growing body of evidence implicates the functional 17 role of NS5A in early steps of virion assembly and morphogenesis (3, 27, 45) . NS5A is a 18 phosphoprotein that migrates in SDS gels as 56 kDa (basally phosphorylated) and 58 19 kDa (hyperphosphorylated) forms of proteins. The C-terminal domain III region of 20 NS5A and the phosphorylated residue (Ser 457 ) are important for virion maturation (3, 21 27, 45) . NS5A domain III contains the binding site for viral core protein indicating the 22 possible involvement of NS5A protein in virus assembly (27) . NS5A anchors to the ER 23 previously (58). HCV infection was performed at an MOI of 1. 1 2
Real-time RT-PCR 3
Total cellular RNAs were purified by AGPC method (7) . Viral RNAs were extracted 4 from 100 µl of supernatant by AGPC method. Five µg yeast transfer RNA was added 5 as a carrier (Sigma-Aldrich). HCV RNA was quantified on ABI Prism 7000 sequence 6 detection system (Applied Biosystems, Foster City, CA) as described previously (43). 7
For the quantification of OSBP mRNA, 100 ng of total cellular RNA was subjected to 8 cDNA synthesis using Improm II reverse transcriptase (Promega) using oligo-dT as 9
primer. Molecular copy number of OSBP and GAPDH cDNA was quantified by real-10 time PCR using SYBR premix Ex Taq (Takara mirus Bio, Madison, WI) in absolute 11 quantification manner. The following set of primers was used for qPCR. OSBP: sense: 12 5'-agaatacccttcggaccctctc-3', anti-sense: 5'-tcttttcattgctctcagcagg-3'. GAPDH; sense: 13 5'-gccatcaatgaccccttcatt-3', anti-sense: 5'-ttgacggtgccatggaattt-3'. 14 15
Western blotting analysis and Immunoprecipitation 16
Huh7 cells or HCV-infected Huh7 cells were transfected with indicated expression 17 vectors by lipofection using TransIT-LT1 reagent (Mirus Bio, Madison, WI). Cells 18 grown in 35mm dish were transiently transfected and incubated for 24 h, washed once 19 with ice-cold PBS and lysed on ice with 500 µl lysis buffer (0.2 % w/v deoxycholic 20 acid, 20 mM Tris/HCl, 150 mM NaCl, 0.1 mM EDTA, 250 mM sucrose), supplemented 21 with 1x concentration of Halt Protease inhibitor single-use cocktail (Thermo Scientific, 22 Rockford, IL). The cellular lysates were subjected to brief sonication followed by 23 centrifugation at 13,400 x g for 10 min. The clarified lysates were incubated with 5 µg 1 of anti-FLAG M2 monoclonal antibody (Sigma-Aldrich) for 1 h. 5 µl of Protein G 2 Sepharose 4 Fast Flow was added (GE Healthcare, Piscataway, NJ) for 2h. Sepharose 3 beads were collected by centrifugation and washed four times with 1 ml of lysis buffer. 4
The immunoprecipitates were analyzed by SDS-PAGE. Immunoblotting analysis was 5 performed as described previously (52). Following antibodies were used for western 6 blotting analysis; mouse monoclonal anti-core (Affinity Bioreagents, Golden, CO), goat 7 polyclonal anti-OSBP (Novus biological, Littleton, CO), goat polyclonal anti-8 apolipoprotein B-100 (Chemicon International, Temecula, CA), rabbit polyclonal anti-9 human albumin (MP Biomedicals, Solon, OH), rabbit polyclonal anti-ADRP (Novus 10 Biological), mouse monoclonal anti-Fatty acid synthase (BD Bioscience) and mouse 11 monoclonal anti-NS3 (Virogen), NS5A, monoclonal antibody 9E10/A3 (a generous gift 12 from Dr. C. Rice). 13 
14

Immunofluorescence microscopy 15
Infected and/or transfected cells were grown on glass coverslips, washed twice with 16 phosphate-buffered saline (PBS), and fixed in 3% paraformaldehyde in PBS, 17 supplemented with 2 mM MgCl2 and 1.25 mM EGTA, for 20 m at room temperature. 18
Fixed cells were permeabilized and blocked in antibody-binding buffer (PBS, 0.2% w/v 19 saponin, 0.2% w/v non-fat dry milk, 1% w/v bovine serum albumin and 0.02% sodium 20 azide) for 2 h at 4C. Fixed cells were incubated in the presence of primary antibodies 21 for overnight. The primary antibodies used for immunofluorescence were mouse 22 monoclonal 9E10/A3 for NS5A, goat polyclonal anti-OSBP (Novus), rabbit polyclonal 23 anti-TGN46 (Sigma-Aldrich) and rabbit polyclonal anti-FLAG (Anaspec, San Jose, 1 CA) to detect FLAG-tagged proteins. Coverslips were washed three times with PBS and 2 once with antibody-binding buffer, followed by the incubation with corresponding 3 secondary antibodies for the detection of primary antibodies. These were; donkey 4 antibodies against mouse (DyLight 488), rabbit (DyLight 549) and goat (DyLight 649, 5 Rockland Immunochemicals, Gilbertsville, PA). The slides were analyzed by confocal 6 laser scanning microscope (Zeiss LSM 510), using 488 nm, 543 nm and 633 nm laser 7 lines. The nuclei were counterstained by DAPI (Invitrogen, Carlsbad, CA). 8
RESULTS 1
Identification of host factors associated with RNP complexes 2
To identify host factors involved in HCV RNA replication, we employed an 3 affinity-based purification procedure to isolate RNP complexes under non-denaturing 4 conditions. We inserted an affinity-tag peptide called One-STrEP-tag (28 amino acid 5 residues) in the C-terminal region of NS5A of subgenomic replicon constructs (Fig.  6 S1A), and established stable replicon cell lines. This insertion did not interfere with the 7 replication of HCV replicon RNA (Fig. S1B ) and or developing G418-resistant clones 8 (Fig. S1C) . We developed, a one-step, non-denaturing affinity column chromatography 9 procedure, for the isolation of NS5A-binding proteins or protein complexes. Purified 10 protein complexes were analyzed by Western blot assay ( Fig. S2A and B) . Viral protein 11 complexes purified by this method were subjected to proteomic MudPIT analysis, 12 which revealed a large repertoire of cellular factors (supplementary Tables S2-7) and 13 included all the viral nonstructural proteins. Western blot analysis of the isolated 14 proteins demonstrated the association of host factors that were identified by proteomic 15 analysis (Fig. S2C, right panels) . In this analysis, we chose proteins whose peptide 16 spectrum counts were significantly high. Fig. S2C shows the association of apoB, 17 OSBP, adipose differentiation related protein (ADRP), and fatty acid synthase along 18 with the representative HCV NS protein, NS5A and NS3. In contrast, these proteins, 19 including NS5A, were not detected in the eluted fractions prepared from wild type 20 replicon (without the One-STrEP-tag) lysates (Fig. S2C, left To demonstrate the functional role of this interaction, we employed RNA 4 interference strategy. We developed lentiviral vectors encoding two OSBP-specific 5 short-hairpin RNAs (shRNA-1, -2). These shRNAs have been previously reported to 6 suppress OSBP mRNA synthesis effectively (31, 36) . Huh7.5.1 cells were first infected 7 with either of lentiviral particle encoding shRNA and subsequently challenged with 8 tissue culture grown HCV (HCVcc) particle at a multiplicity of infection 1 (MOI). A 9 lentivirus encoding a scrambled shRNA was used as a negative control. OSBP 10 expression was monitored by Western blot assays ( Fig. 2A) and by RT-PCR analysis 11 respectively (Fig. 2B ). OSBP shRNAs-1 and, -2 expressing cells displayed differential 12 levels of suppression of OSBP protein ( Fig. 2A, top) . OSBP protein was barely 13 detectable in shRNA-1 expressing cells. On the other hand, the reduction of OSBP was 14 modest in shRNA-2 expressing cells. OSBP protein appears as a doublet representing 15 differentially phosphorylated forms. Albumin levels were uniformly expressed in these 16 lysates ( Fig shRNA-2, on the other hand, modestly reduced their expression (Fig. 2 , lower panels). 21 We next performed quantitative RT-PCR analyses of OSBP mRNA and viral RNAs 22 isolated from cellular extracts (intracellular) and culture supernatants (extracellular). 23 Intracellular RNA levels indicate viral replication whereas, extracellular viral RNA is a 1 measure of released viral particles in the culture supernatant. The results show that both 2 shRNAs were effective in suppressing OSBP mRNA synthesis (63% and 53%, 3 respectively) without affecting GAPDH mRNA level ( Fig. 2B and C) . Unrelated 4 scrambled shRNA (control) did not have any effect on OSBP mRNA synthesis (Fig.  5 2C). ShRNA-1, which was more potent in silencing the OSBP mRNA (63% 6 reduction) (Fig. 2B ), significantly suppressed intracellular levels of HCV RNA (85% 7 reduction) (Fig. 2D ). ShRNA-2 on the other hand, which caused a modest reduction of 8 OSBP mRNA (53%) compared to the shRNA-1 (Fig. 2B ), reduced the intracellular 9 HCV RNA replication levels only modestly (14%) (Fig. 2D ). When analyzed for 10 extracellular virion RNA levels, both shRNA-1 and -2 effectively blocked the release of 11 viral particles in the culture medium (99.8% and 87.2 % reduction, respectively) ( Fig.  12   2E ). More importantly the shRNA-2, which has little effect on intracellular HCV RNA 13 replication levels, dramatically reduced the HCV release (Fig. 2E ). We further 14 confirmed these results by determining the foci-forming units of the cultured 15 supernatant as described previously (58 One of the unique characteristics of the OSBP protein is its ability to translocate 6 to the Golgi apparatus upon ligand binding. The translocalization of OSBP is regulated 7 by its PH domain, which binds to Golgi lipid such as PI4P (Fig. 1A) . The RNA 8 interference studies described above suggest that partial depletion of OSBP can cause 9 inhibition of viral particle secretion. To elucidate the functional role of OSBP in virion 10 maturation processes further, we generated several mutants of OSBP (Fig.1B) . These 11 include; an N-terminal region of OSBP containing only the PH domain fragment (N-12 PH), a deletion in the PH domain (∆PH), a base substitution mutation in the PH domain, 13 W172A (53) and mutation in the FFAT motif, FF/AA (54) (Fig. 1B) . Wild type OSBP 14 and the mutants were transiently transfected into Huh-7 cells and analyzed for their 15 subcellular distribution by indirect fluorescence microscopy using anti-FLAG antibody 16 (OSBP and all OSBP mutants contain a FLAG-tag at their N-termini). Cells were 17 counterstained with TGN46 antibody (Trans-Golgi network protein 46kDa) and DAPI. 18
Both wild type OSBP and the PH domain-containing mutant (N-PH) predominantly 19 localized to the Golgi (Fig. 3) . N-PH mutant displayed Golgi localizations, as a 20 consequence of its exposed PH domain. Other mutants including the PH deletion (∆PH) 21 and the base substitution mutants (W172A, FF/AA), in general, displayed a diffuse 22 cytosolic pattern of OSBP. Both W172A and FF/AA mutants showed a punctate pattern 23 of OSBP distribution in the cytosol and appear to induce a distortion of trans-Golgi 1 network (Fig. 3) . The OSBP mutant FF/AA displayed partial Golgi localization. The 2 substitutions of two-phenylalanine residues in FFAT motif abolish its ability to bind 3 VAP-A (53,54). VAP-A has been previously shown to bind NS5A (13, 17) . 4
These OSBP mutants were also introduced into HCV infected cells and 5 examined for their effect on replication and viral particle release. Fig. 4C , shows a 6
Western blot analysis of HCV infected cells expressing ectopically expressed OSBP 7 and its mutants. None of the OSBP mutants affected intracellular HCV RNA 8 replication to any significant degree (Fig. 4B) . However, the extracellular accumulation 9 of viral RNA was affected by the ∆PH OSBP mutant (Fig. 4A) . PH domain is essential 10 for the OSBP translocalization to the Golgi (24) . Other mutants did not have any 11 significant effect on the viral particle release except for W172A mutant. Surprisingly, 12 the mutant W172A showed a modest increase in the viral particle release. At present, 13
we have no explanation for this observed result but further characterization of this 14 mutant will be needed. To further confirm the effect OSBP mutants on HCV release, 15 chimeric HCV vector containing luciferase reporter gene, analogous to , 16 was constructed and tested for virus production in the presence of OSBP mutants (Fig.  17   4D ). Again, ∆PH mutant consistently showed inhibitory effect on viral particle release 18 assayed by luciferase activity of released "reporter" virus. Taken together, the failure of 19 ∆PH OSBP mutant to maintain wild type levels of viral particle release indicates that 20 OSBP likely involved in the viral particle release via the Golgi compartments. OSBP was identified, in this study, as an NS5A-associated protein (Fig. S2C) . 2 NS5A has been previously shown to interact with VAP-A and VAP-B (17). VAP-A 3 also has been reported to bind OSBP (53). We have confirmed these interactions by 4 immunoprecipitation study. NS5A was shown to interact with OSBP and VAP-A (Fig.  5   S3A) . We further examined that OSBP interacts with NS5A irrespective of its 6 genotypic origin. NS5A derived from genotype 1b (con1) or 2a (JFH1) binds to OSBP 7 (Fig. S3B) . 8
We next mapped the binding site(s) of OSBP within the NS5A protein. Huh- 7 9 cells were co-transfected with FLAG-tagged OSBP vector and various NS5A deletion 10 mutants respectively. All NS5a expression vectors contain a Myc/His tag (Fig. 5A) . 11
Cellular lysates were immunoprecipitated with anti-FLAG antibody to capture OSBP 12 followed by immunoblotting with anti-Myc antibody to probe for NS5A. Cellular 13 lysates were immunoprecipitated with anti-FLAG antibody to capture OSBP followed 14 by immunoblotting with anti-Myc antibody to probe for NS5A. Cellular lysates were 15 examined for NS5A and OSBP expression by Western blot assays (Fig. 5B, upper and  16 middle panels respectively). The results show that C-terminal amino acid (aa) residues 17 of NS5A which range from aa 126 to 447 remained associated with OSBP ( Fig. 5B  18 lower panel). These preliminary mapping studies identify domain I of NS5A as the 19 approximate binding site(s) for OSBP. A more clearly defined motif of NS5A region 20 harboring OSBP binding needs to be identified. The interaction between NS5A and 21 OSBP was also supported by the merged images of these proteins by confocal 22 immunofluorescence microscopy, which displays a Golgi-like pattern (Fig. S4) images in light blue color (Fig. 6, top row) . When Huh 7 cells were stimulated by 25-10 HC, OSBP displayed a discrete and predominant Golgi localization (Fig. 6, second  11 row). When we analyzed the subcellular distribution of NS5A upon 25-HC stimulation 12 in the HCV (JFH1) infected cells, NS5A in addition to its typical punctate ER 13 localization, also displayed a discrete localization to the TGN. The merged image of 14 OSBP and NS5A localization in the Golgi can be seen in yellow color (Fig. 6, bottom  15 
row). 16
We also examined this phenomenon in cells expressing NS5A gene via an 17 ectopic expression vector encoding NS5A. As can be seen, the addition of 25-HC again 18 triggered its Golgi distribution, suggesting that NS5A via its interaction with OSBP is 19 targeted to the Golgi (Fig. S4B) . This result suggests that NS5A can localize to the 20 Golgi in the absence of other viral proteins or without the context of HCV infection. Using RNA interference studies, it is shown that partial depletion of OSBP did 7 not affect HCV replication but dramatically inhibited the accumulation of HCV 8 particles ( Fig. 2B-E) . OSBP-specific shRNA-1, which severely depleted OSBP protein, 9
affected both viral RNA replication and virion secretion. Such a depletion of OSBP by 10 shRNA-1 also affected viral gene expression ( Fig. 2A) , suggesting that OSBP may be 11 proportionally affected by this shRNA (Fig. 2A) . Intracellular levels of viral RNA were 17 not affected but the accumulation of extracellular RNA was severely reduced. This 18 result suggested the involvement of OSBP in virion secretion. 19
Mutations within the functional domains of OSBP that affect its various functions 20 have been described (50). We developed a few of these OSBP mutations and ectopically 21 expressed them in HCV infected cells (Fig. 1B) . Most of these mutations displayed 22 diffuse patterns of OSBP with reduced Golgi localizations (W172A, FF/AA). The PH 23 domain deletion mutant, ∆PH, failed to localize to the Golgi impairing the virion release 1 (Fig. 2D and E) . Overall results of this study, point more emphatically to a major role 2 of OSBP in the regulation of virion secretion. 3
Several studies support the notion that HCV may utilize the VLDL secretory 4 pathway (6, 14, 19, 29) . The most compelling evidence comes from the use of 5 microsomal triglyceride transfer protein (MTP) inhibitor and apoB silencing studies, 6 both of which affect the VLDL particle assembly (14) . MTP inhibitor and apoB siRNA 7 affect the accumulation of extracellular viral RNA while not affecting the intracellular 8 viral RNA replication (14) . Use of an antioxidant flavonoid Naringenin, which inhibits 9 VLDL assembly, similarly inhibited virion release (29). Huang and colleagues showed 10 that secretion of HCV infectious particles is dependent on active secretion of VLDL, 11 showing that VLDL assembly/secretion pathway is being utilized by HCV (19) . Pre-12 VLDL particles are assembled in the ER and mature VLDL particles formation occurs 13 in the Golgi (16). While it is not known whether OSBP localization and/or trafficking 14 to the Golgi are needed for VLDL secretion, we show here that NS5A along with OSBP 15 is also localized to the Golgi besides its characteristic localization in the ER. Our 16 confocal microscopy studies show a notable fraction of NS5A is localized to the Golgi 17 (Fig. 6) . These data implicate a pivotal role of NS5A in virion maturation process, 18 which likely occurs in the Golgi compartments. NS5A interacts with OSBP via its N-19 terminal residues and this interaction may be needed for NS5A's localization to the 20 Golgi as well. The preliminary data presented here maps the binding site(s) of OSBP 21 within the domain I of NS5A (Fig. 4) . Exact motifs involved in this interaction remain 22 to be characterized. NS5A has three functional domains (I, II, III). Domains I and II are 23 relevant to the regulation of HCV RNA replication. Several studies point to the role of 1 domain III in HCV particle secretion (3, 27, 45) . Serine 457 residue in this domain in 2 particular, which is also the site of casein kinase II phosphorylation, has been shown to 3 be essential for virion production (45) . It will be of interest to determine the Golgi 4 localization of NS5a Ser 457 mutant. Importance of Golgi trafficking for HCV life cycle 5 is further supported by the observations that HCV envelope proteins traffic thorough the 6 cisternae of Golgi for glycosylation (32) . Little is known about the HCV assembly and 7 secretion processes. The studies described herein represent attempts to probe into these 8 processes. Clearly the delineation of these pathways is needed for the elucidation of 9 HCV life cycle and its relevance to infectious processes. 10
In summary, we have demonstrated that OSBP function(s) are relevant to HCV 11 maturation process. Our studies also suggest that NS5A localizes to the Golgi and that 12 OSBP and NS5A together aid in the viral assembly and or secretion processes. 
